BIOLASE, Inc. (NASDAQ:BIOL) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $0.05 in the quarter versus EPS of $-0.06 in the year-earlier quarter. Revenue Rose 45.14% to $19.1 million from the year-earlier quarter.
BIOLASE, Inc. reported adjusted EPS income of $0.05 per share. By that measure, the company beat the mean analyst estimate of $0. It beat the average revenue estimate of $18.03 million.